MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 36471-36480 Newer>
The Motley Fool
May 26, 2009
Christopher Barker
The Top 10 Reasons to Hold Gold: Part 1 As the dollar deteriorates, gold remains the ultimate safe haven. mark for My Articles 976 similar articles
The Motley Fool
May 26, 2009
Rich Smith
Should Size Really Matter for Defense Investors? Some of the most innovative and fastest-growing companies in the defense sector are companies you've never heard of before, like Israeli aircraft maker Elbit Systems, or night-vision camera maker FLIRSystems. mark for My Articles 170 similar articles
The Motley Fool
May 26, 2009
Brian Orelli
When Higher Costs Are a Good Thing The Food and Drug Administration proposed its budget for the next fiscal year, including user fees for pharmaceutical companies. But GlaxoSmithKline, Merck, and the rest of the industry probably won't complain too loudly. mark for My Articles 1013 similar articles
The Motley Fool
May 26, 2009
Rich Smith
This Just In: Upgrade or Downgrade KeyBanc thinks mining equipment makers Joy Global and Bucyrus are well poised for the future and upgrade both. mark for My Articles 49 similar articles
The Motley Fool
May 26, 2009
Anders Bylund
Cloud Computing by Mail! Amazon has launched a beta service that lets you send in a data-packed hard drive by mail. mark for My Articles 800 similar articles
The Motley Fool
May 26, 2009
Brian Orelli
A Less-Risky Stem Cell Play Life Technologies is a clear leader in stem cell reagents. mark for My Articles 277 similar articles
The Motley Fool
May 26, 2009
Tim Beyers
These Tech Stocks Will Make Me Rich Week 41 of one analyst's real-money investment in five technology stocks. mark for My Articles 648 similar articles
The Motley Fool
May 26, 2009
Brian Orelli
Buy Now! It Might Get Bought! Clinical trial results and FDA approvals ultimately drive any increase in drugmakers' value. That's what pharmaceutical investors should focus on. The potential for an acquisition should be nothing more than icing on the cake. mark for My Articles 394 similar articles
The Motley Fool
May 26, 2009
Toby Shute
A Spark for Yingli Green Energy Yingli may just emerge from the current crunch stronger than when it entered it. mark for My Articles 679 similar articles
The Motley Fool
May 26, 2009
Selena Maranjian
You Can Make a Difference Shareholders can propose changes for companies, and if they gain enough support, they can make a big difference. mark for My Articles 177 similar articles
<Older 36471-36480 Newer>    Return to current articles.